In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
出版年份 2015 全文链接
标题
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
作者
关键词
-
出版物
NATURE GENETICS
Volume 47, Issue 10, Pages 1212-1219
出版商
Springer Nature
发表日期
2015-08-24
DOI
10.1038/ng.3391
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- (2015) Charlotte KY Ng et al. GENOME BIOLOGY
- In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics
- (2015) Ida Grundberg et al. Oncotarget
- Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
- (2014) Glenn Deng et al. BMC CANCER
- Genetic and Phenotypic Diversity in Breast Tumor Metastases
- (2014) V. Almendro et al. CANCER RESEARCH
- PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma
- (2014) R. A. Sakr et al. CLINICAL CANCER RESEARCH
- Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
- (2014) Andriy Marusyk et al. NATURE
- Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
- (2014) Charlotte Giesen et al. NATURE METHODS
- Highly Multiplexed Subcellular RNA Sequencing in Situ
- (2014) J. H. Lee et al. SCIENCE
- Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
- (2014) Vanessa Almendro et al. Cell Reports
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
- (2013) M Cizkova et al. BRITISH JOURNAL OF CANCER
- The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis
- (2013) Yaohui Wang et al. CURRENT MEDICAL RESEARCH AND OPINION
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
- (2013) A. B. Hanker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer
- (2012) S. Chandarlapaty et al. CLINICAL CANCER RESEARCH
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- (2012) T. A. Yap et al. Science Translational Medicine
- Evolutionary Pathways in BRCA1-Associated Breast Tumors
- (2012) Filipe C. Martins et al. Cancer Discovery
- HeterogeneousHER2Gene Amplification
- (2011) Alastair I. Bartlett et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- (2011) Benjamin J. Hindson et al. ANALYTICAL CHEMISTRY
- Immunophenotypic and genomic characterization of papillary carcinomas of the breast
- (2011) Raphaëlle Duprez et al. JOURNAL OF PATHOLOGY
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
- (2010) So Yeon Park et al. JOURNAL OF CLINICAL INVESTIGATION
- Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neuAmplification
- (2009) Matteo Brunelli et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Equivocally AmplifiedHER2FISH Result on Breast Core Biopsy
- (2008) Joan M. Striebel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- PCR-amplification of GC-rich regions: 'slowdown PCR'
- (2008) Ulrich H Frey et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now